Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji-Hun Jang

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Journal of Clinical Pharmacology|February 16, 2026
Physiologically Based Pharmacokinetic Modeling of Lurasidone, an Antipsychotic Drug: Impact of CYP3A4 Polymorphisms and Hepatic Impairment on Exposure and Dose OptimizationSeung-Hyun Jeong, Yunha Noh, Ji-Hun Jang
Pharmaceuticals (Basel, Switzerland)|September 5, 2020
Pharmacokinetic Comparison of Three Different Administration Routes for Topotecan Hydrochloride in RatsSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Environmental Pollution (Barking, Essex : 1987)|August 28, 2022
Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamicsSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Journal of Pharmaceutical Sciences|September 3, 2022
Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with CirrhosisSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 8, 2024
Exploring gender differences in pharmacokinetics of central nervous system related medicines based on a systematic review approachSeung-Min Lee, Ji-Hun Jang, Seung-Hyun Jeong
Environmental Pollution (Barking, Essex : 1987)|August 20, 2023
Inter-individual exposure variability interpretation through reflection of biological age algorithm in physiologically based toxicokinetic model: Application to human risk assessment of di-isobutyl-phthalateSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Biomedicines|November 25, 2023
Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic-Pharmacodynamic ModelingSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Pharmacokinetic Analysis of Levodropropizine and Its Potential Therapeutic Advantages Considering Eosinophil Levels and Clinical IndicationsJi-Hun Jang, Young-Jin Cho, Seung-Hyun Jeong
Journal of Pharmaceutical Analysis|July 13, 2023
Quantitative assessment of the relevance of organic-anion-transporting-polypeptide 1B1 and 2B1 polymorphisms in fexofenadine pharmacokinetic variants via pharmacometricsJi-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Pharmaceutics|October 21, 2020
Enhanced Lymphatic Delivery of Methotrexate Using W/O/W Nanoemulsion: In Vitro Characterization and Pharmacokinetic StudyJi-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Journal of Clinical Pharmacology|February 16, 2026
Physiologically Based Pharmacokinetic Modeling of Lurasidone, an Antipsychotic Drug: Impact of CYP3A4 Polymorphisms and Hepatic Impairment on Exposure and Dose OptimizationSeung-Hyun Jeong, Yunha Noh, Ji-Hun Jang
Pharmaceuticals (Basel, Switzerland)|September 5, 2020
Pharmacokinetic Comparison of Three Different Administration Routes for Topotecan Hydrochloride in RatsSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Environmental Pollution (Barking, Essex : 1987)|August 28, 2022
Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamicsSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Journal of Pharmaceutical Sciences|September 3, 2022
Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with CirrhosisSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 8, 2024
Exploring gender differences in pharmacokinetics of central nervous system related medicines based on a systematic review approachSeung-Min Lee, Ji-Hun Jang, Seung-Hyun Jeong
Environmental Pollution (Barking, Essex : 1987)|August 20, 2023
Inter-individual exposure variability interpretation through reflection of biological age algorithm in physiologically based toxicokinetic model: Application to human risk assessment of di-isobutyl-phthalateSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Biomedicines|November 25, 2023
Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic-Pharmacodynamic ModelingSeung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Pharmacokinetic Analysis of Levodropropizine and Its Potential Therapeutic Advantages Considering Eosinophil Levels and Clinical IndicationsJi-Hun Jang, Young-Jin Cho, Seung-Hyun Jeong
Journal of Pharmaceutical Analysis|July 13, 2023
Quantitative assessment of the relevance of organic-anion-transporting-polypeptide 1B1 and 2B1 polymorphisms in fexofenadine pharmacokinetic variants via pharmacometricsJi-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Pharmaceutics|October 21, 2020
Enhanced Lymphatic Delivery of Methotrexate Using W/O/W Nanoemulsion: In Vitro Characterization and Pharmacokinetic StudyJi-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Pageof 12